MADISON PETTY: Open Payments
NPI 1205545761 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,598 in 68 payments from 25 companies in 2025. Trend: 2023 $113 · 2024 $287 · 2025 $1,598
Food & beverage: $1,598
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $268 |
| Janssen Biotech, Inc. | 10 | $266 |
| PFIZER INC. | 5 | $95 |
| Merck Sharp & Dohme LLC | 3 | $89 |
| Telix Pharmaceuticals | 3 | $85 |
| ABBVIE INC. | 4 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| UROGEN PHARMA, INC. | 4 | $80 |
| Dendreon Pharmaceuticals LLC | 3 | $78 |
| Antares Pharma, Inc. | 4 | $62 |
Products named: Nubeqa, ERLEADA, Xtandi, KEYTRUDA, ILLUCCIX, GEMTESA, PROVENGE, XYOSTED.
Industry payments across NV — which companies pay providers there.
